Stoke Therapeutics Grants Options for 245,920 Shares to 18 New Employees
Stoke Therapeutics granted newly appointed Senior Vice President, Chief Information Officer Stephen Aschettino stock options to purchase 70,000 common shares. Seventeen other new employees received stock options covering 175,920 common shares. All grants took effect October 15, 2026. The options carry an exercise price